Evidence map›Paper›PMID 14962963›Full record

ArticleAnnals of the rheumatic diseases2004

Polymorphisms in the tumour necrosis factor gene are not associated with severity of inflammatory polyarthritis.

A Barton, H Platt, F Salway, D Symmons, E Barrett, M Bukhari, M Lunt, E Zeggini, S Eyre, A Hinks and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in Annals of the rheumatic diseases, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
3.0field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 36 citations in OpenAlex.

  1. Guideline
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 1 country.

A BartonUniversity of Manchester, UK. Barton@fs1.ser.man.ac.uk
H Platt
F Salway
D Symmons
E Barrett
M Bukhari
M Lunt
E Zeggini
S Eyre
A Hinks
D Tellam
B Brintnell
W Ollier
J Worthington
A Silman
University of Manchester · GBSerco (United Kingdom) · GB

Funding

Arthritis Research UK 17552
6 · The paper itself

Abstract

backgroundTumour necrosis factor alpha (TNFalpha) is a powerful inflammatory mediator in rheumatoid and other types of inflammatory arthritis. Polymorphisms within the TNFalpha gene have previously been investigated to determine their role in the aetiopathogenesis of rheumatoid arthritis (RA), but it is unclear whether reported associations are with susceptibility to, or severity of, disease.

objectiveTo examine the association between both individual TNFalpha single nucleotide polymorphisms (SNPs) and haplotypes with the development and severity of erosions by 5 years in patients with inflammatory polyarthritis (IP).

methods438 patients from the Norfolk Arthritis Register observational inception cohort of patients with IP were x rayed 5 years after disease onset. They were genotyped for nine SNPs mapping to the TNFalpha gene, using a SNaPshot primer extension assay. Haplotypes were constructed in patients with IP, who were compared for the presence and extent of erosions at 5 years.

resultsNo association between individual TNFalpha SNPs or haplotypes in the patients who developed erosions at 5 years compared with those who remained non-erosive was found. Restricting analysis to patients who satisfied ACR criteria for RA by 5 years did not affect the conclusions.

conclusionThe TNFalpha gene does not seem to be associated with severity as assessed by erosive outcome at 5 years in patients with IP.

Indexed as

Polymorphism, Single NucleotideArthritisArthrographyChi-Square DistributionFemaleFollow-Up StudiesGenotypeHaplotypesHumansMaleMiddle AgedRheumatoid FactorTumor Necrosis Factor-alphaRheumatoid FactorTumor Necrosis Factor-alpha

Identifiers

PMID14962963
PMCPMC1754913
OpenAlexW2113193320

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.